DCTHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
DELCATH SYSTEMS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$14.37+0.29 (+2.06%)
Close on Oct 19, 2026
- Market cap
- $571.37M
- P/E (TTM)
- 1437.0
- Dividend yield
- –
DELCATH SYSTEMS, INC. revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HEPZATO KIT | $88.72M | $84.06M | $78.84M | $73.46M | $64.25M | $48.32M | $32.30M | $18.62M | $8.58M | $2.01M | $0 | – | 93.0% | +38.1% |
| CHEMOSAT | $6.70M | $6.38M | $6.40M | $6.14M | $5.99M | $5.53M | $4.90M | $4.03M | $3.30M | $2.60M | $2.07M | – | 7.0% | +11.8% |
| Product revenue | – | – | – | – | – | – | – | – | – | – | $2.07M | $2.17M | – | – |
| Other revenue | – | – | – | – | – | – | – | – | – | – | $0 | $0 | – | – |
By region
From the segment and revenue-disaggregation notes of Delcath Systems's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.